From Cancer to Victory: One Woman’s Journey to Health and Resilience - Dr Kelly Victory

By Editorial Team

Introduction: Early Detection Saves Lives

In July 2023, a routine mammogram changed everything for Dr. Kelly Victory. Despite leading a healthy lifestyle — exercising regularly, eating a low‑sugar diet, and avoiding smoking — a small lump was detected. Early detection, swift action, and a proactive approach were key to her journey toward recovery.

“Even when you feel healthy, cancer doesn’t always send warnings. Early screening can be lifesaving.” — Dr. Kelly Victory


Dr Kelly Victory, discusses February as National Cancer Prevention Month on Fox News, emphasizing metabolic and immune health for lowering cancer risks.

For decades, cancer has been framed as sudden. Random. Unpredictable.

But that story is incomplete.

Cancer doesn’t start overnight.
It develops quietly — reinforced by daily habits.
  • Chronic stress.
  • Poor sleep.
  • Processed diets.
  • Sedentary routines.
  • Environmental toxins.
Modern life often works against the body’s natural defenses.

And while not all cancers are preventable, many risk factors are.

Global health estimates suggest 30–50% of cancers may be preventable through nutrition and lifestyle changes.

That’s not inevitability.
That’s opportunity.

Dr. Kelly Victory emphasizes that cancer is not a single disease — but a process shaped by immune function, inflammation, metabolic health, and environmental exposure.

Prevention is possible through strengthening the body’s baseline resilience — the systems that monitor and repair cellular damage every day.

“Prevention begins long before diagnosis,” she notes, underscoring the importance of supporting the body’s natural defenses before disease takes hold.

Individually, these changes may seem small.
Collectively, they reshape the terrain in which disease either struggles — or thrives.

Acting Fast: From Diagnosis to Treatment

Rather than waiting six months for a follow-up, Dr. Victory consulted a surgeon within days. The mass was surgically removed, revealing an aggressive tumour, though fortunately, her lymph nodes were cancer-free. She underwent 25 rounds of radiation therapy and continues regular six-month screenings to maintain her health.

Key takeaway: Early action and informed decision-making are crucial when facing a cancer diagnosis.

Lessons Learned from Cancer Survival

Cancer impacts every aspect of life — physically, emotionally, and mentally. Dr. Victory emphasizes the importance of combining medical treatment with lifestyle strategies that support overall well-being.

Evidence-based tips for newly diagnosed patients:

  1. Seek multiple medical opinions.
    Second opinions from oncology specialists can provide clarity on treatment options.

  2. Understand your diagnosis.
    Learn your cancer type, stage, and prognosis to make informed decisions.

  3. Ask detailed questions.
    Discuss risks, benefits, and side effects of each treatment option with your care team.

  4. Consider long-term outcomes.
    Understanding recurrence risks and survival rates helps with planning and peace of mind.

References: American Cancer Society – Coping with Cancer, National Cancer Institute – Survivorship

Lifestyle Practices that Support Recovery

While medical treatment is essential, Dr. Victory adopted complementary wellness habits to strengthen resilience and overall health:

  • Stress management: Journaling, mindfulness, and community support.

  • Balanced nutrition: Focus on whole foods, minimizing processed sugars.

  • Daily physical activity: Walking, stretching, and outdoor movement.

  • Limiting harmful substances: Avoiding tobacco and excessive alcohol.

  • Micronutrient support: Vitamin D and zinc supplementation — always under medical supervision.

Wellness practices complement but do not replace standard cancer therapies.

Introducing the SHIELD Protocol

Inspired by her journey, Dr. Victory developed the SHIELD protocol, integrating science-backed lifestyle strategies with supportive botanicals:

  • A daily polyphenol-rich cocoa blend with turmeric, adaptogens, and green tea extract to support antioxidant defenses, immune balance, and inflammation.
  • A targeted botanical soft gel with olive leaf extract, berberine, oregano oil, and black cumin seed oil to support immune and metabolic pathways involved in cellular protection and detox.
If you’re serious about stacking the odds, start with the fundamentals — screenings, movement, sleep, nutrition, and limiting alcohol — then add SHIELD as a daily layer of support alongside your physician-led plan.


Important Note: While preliminary studies suggest these ingredients may support immune health, there is no robust clinical evidence that they prevent or treat cancer. They should only be used alongside conventional therapies, under professional guidance.


SHIELD (cellular immunity, detoxification, and longevity)

Check Price

SHIELD is a first-to-market, dual-delivery cellular defense protocol uniquely designed to powerfully support immunity, reduce inflammation, and protect against environmental and internal stressors. Formulated by Dr. Kelly Victory, it combines a rich antioxidant cocoa drink with a targeted botanical softgel to deliver full-spectrum support — from cellular detox to immune restoration and longevity promotion.

Emotional Resilience Matters

Beyond the physical aspects, Dr. Victory highlights emotional and mental support as critical components of survivorship:

  • Building a support network of family, friends, and fellow survivors.

  • Maintaining hope and perspective while acknowledging challenges.

  • Seeking professional mental health support when needed.

Conclusion: Victory Through Awareness and Action

Dr. Victory’s story underscores the power of early detection, informed decision-making, and holistic support. Cancer survival is not just about treatment — it’s about lifestyle, mindset, and proactive care.

“Taking charge of your health, asking questions, and embracing supportive practices can make a meaningful difference.”

References:

  1. twc.health/blogs/news/from-cancer-victory
  2. https://www.twc.health/products/shield

Comments

Post a Comment

Popular posts from this blog

Ivermectin for Cancer Treatment: Protocols and Evidence (2025 Edition)

By Editorial Team
Image
Ivermectin, a drug primarily used to treat parasitic infections, has gained attention for its potential anti-cancer properties, particularly in alternative treatment protocols. Popularized by figures like Dr. William Makis, these protocols combine ivermectin with supplements and lifestyle changes to target aggressive cancers. This article explores the science, protocols, case reports, risks, and controversies surrounding ivermectin’s use in cancer treatment, providing a balanced guide for readers. What is the Ivermectin Cancer Protocol? Ivermectin cancer protocols, notably those developed by Dr. William Makis, combine ivermectin with supplements like curcumin, vitamin D, and berberine, alongside dietary and lifestyle changes. These protocols are tailored to cancer severity, with higher doses recommended for aggressive cases. The term “turbo cancers,” used by some proponents, refers to rapidly progressing cancers, though it is not a standard medical term and lacks clear scientific defin...
Read more

Fenbendazole and the Joe Tippens Protocol: Evidence, Risks, and Current Perspective (2026 Update)

By Editorial Team
Image
Introduction The Joe Tippens Protocol revolves around the off-label use of fenbendazole (a veterinary dewormer commonly sold as Panacur C or Safe-Guard) combined with various supplements for cancer. The Protocol has been gaining rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens popularized this approach after claiming it contributed to his remission from metastatic small-cell lung cancer in 2017. As of 2026, Joe Tippens remains alive and reports being cancer-free for over 8 years, continuing a maintenance version of the protocol. Fenbendazole is marketed for animals (e.g., Panacur C, Safe-Guard ) and has no regulatory approval for human cancer treatment . Evidence for anticancer effects is primarily preclinical or anecdotal , and clinical trials in humans are lacking. Important Disclaimer: Fenbendazole is not approved by the FDA, EMA, or any regulatory body for human use or canc...
Read more

Fenbendazole and Ivermectin for Cancer: A Case Series of Over 500 Patients (2026)

By Editorial Team
Image
Anecdotal reports and preliminary studies suggest that ivermectin and fenbendazole, both antiparasitic drugs, may have potential anticancer effects when used alongside other treatments.  Many people immediately dismiss the potential of ivermectin and fenbendazole when they learn it is “horse or dog medicine”. That initial reaction is overcome when genuine human success stories are told including the lack of serious side effects. The testimonials you are about to read are from individuals who have bravely shared their experiences in the hope of inspiring and uplifting others. These are raw human accounts, unfiltered by gatekeepers—not peer-reviewed studies—but they offer insights that may be valuable to those searching for options. However, we acknowledge that robust clinical trials are needed to provide more conclusive scientific evidence. Contents: Editor's Preface Introduction Fenbendazole and Ivermectin Case Series Compilation (alphabetical) Breast Cancer Success Stories  (...
Read more

Exploring Ivermectin, Mebendazole and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2025)

By Editorial Team
Image
Fenbendazole and ivermectin, both antiparasitic drugs that have shown potential in cancer treatment through several mechanisms, such as slowing cancer cell growth and boosting the immune response. Fenbendazole is being studied for its ability to disrupt energy production in cancer cells, effectively hindering their growth. Ivermectin, on the other hand, has been explored in combination with checkpoint inhibitors to boost the immune system's response to tumors—especially in challenging cases like triple-negative breast cancer. Introduction Cancer remains a leading cause of morbidity and mortality worldwide, with an increasing incidence of aggressive and treatment-resistant tumors such as triple-negative breast cancer (TNBC), pancreatic adenocarcinoma, and glioblastoma. Despite significant advances in targeted therapies and immunotherapies, many patients continue to face limited effective options, highlighting an urgent need for novel, affordable, and accessible treatment strategies....
Read more

Fenbendazole vs Ivermectin for Cancer: Differences and Which Is Better?

By Editorial Team
Image
Cancer patients are increasingly inquiring about the use of the anthelmintic drugs Fenbendazole (FenBen) and Ivermectin (IVM) as potential treatments for cancer. Notably, these patients typically fall into two distinct groups, neither of which represents the usual stage 1 or 2 cancer cases where conventional therapies often show promise. The first group consists of older men whose lung or prostate cancer has recurred. Having undergone conventional treatments previously without success, they express skepticism about its effectiveness this time around. The second, larger group comprises younger patients under 40 dealing with aggressive breast cancer, colorectal cancer, or lymphoma—forms of early-onset cancers that appear to lack the typical mutations observed in traditional cases. This article aims to delve into the differences between Fenbendazole and Ivermectin by examining their me...
Read more

Top 10 Cancer Fighting Supplements: Evidence Based Literature Review (2025)

By Editorial Team
Image
Are you overwhelmed by conflicting advice on cancer, diet, and supplements ? You’re not alone. With so many claims out there, it’s hard to separate fact from fiction . Can certain foods lower your cancer risk ? Are some foods increasing it without you realizing? What about vitamin and mineral supplements —do they help prevent cancer, or could they actually increase your risk ? The term " anti-cancer supplements " can be misleading. While some nutrients support the body in cancer prevention or treatment, others may interfere with therapies or even pose risks. There are presently over 1,500 herbs and food supplements in commerce, many of them with claims in use against cancer. This guide compiles over 500 scientific r...
Read more

Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

By Editorial Team
Image
Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor  Mel Gibson on The Joe Rogan Experience , where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives. Introduction and Context According to a January 22, 2025 fact-check article by AFP: "The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor  Mel Gibson claimed on the Joe Rogan Experience  that they cured his friends' cases of the disease. Oncology ex...
Read more

Fenbendazole and Cancer: What the Science Really Shows (Evidence, Risks & Open Questions)

By Editorial Team
Image
Abstract Background:  Fenbendazole (FBZ), a benzimidazole anthelmintic approved for veterinary use, has attracted attention for potential anticancer activity based on laboratory findings and widespread anecdotal reports.  Objective:  To critically appraise the current evidence on fenbendazole and cancer using a peer‑review style framework.  Methods:  Narrative review of preclinical studies, publicly reported human case narratives, and safety signals, with emphasis on evidence hierarchy and translational limitations.  Results:  Preclinical data demonstrate antiproliferative effects via microtubule disruption and metabolic stress in vitro and in animal models. Human evidence is limited to uncontrolled case reports; no Phase I–III clinical trials or regulatory approvals for oncology exist. Safety data in humans are sparse, with hepatotoxicity signals reported.  Conclusions:  Fenben...
Read more

Best Fenbendazole Dosage for Cancer in Humans: Benefits, Risks, and Guidelines (2025)

By Editorial Team
Image
What is Fenbendazole? Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discover...
Read more

2025 Study: Ivermectin and Balstilimab for Stage 4 Triple Negative Breast Cancer - Cedars-Sinai Medical Center Study

By Editorial Team
Image
Authors: Yuan Yuan, Jin Sun Bitar, MaLia Walker, David Lin, January Lee, So Yung Choi, Stephen Shiao, Mourad Tighiouart, Paul H. Frankel, Peter P. Lee Affiliation: Cedars-Sinai Medical Center, Los Angeles, CA Abstract e13146  (2025 ASCO Annual Meeting) is a phase 1/2 study of ivermectin in combination with balstilimab after 1-2 prior lines of therapy for triple negative breast cancer Background: Despite recent FDA approval of immune checkpoint inhibitor (ICI) and antibody-drug conjugates (ADCs), therapeutic options for metastatic triple negative breast cancer (mTNBC) remain limited. Preclinical data showed that ivermectin induces robust T cell infiltration into breast tumors and turning “cold” tumors “hot” in mouse model of TNBC. Balstilimab is a fully humanized IgG4 anti-PD-1 agent with proven safety and efficacy in metastatic cervical cancer. The current phase I/II trial is designed to test the safety and efficacy of the combination of ivermectin and balstilimab in patients wit...
Read more